Consensus EPS · Q2 2026
$0.03
Consensus revenue · Q2 2026
$725.2M
Analysts
5
Expected report
Aug 4, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 5 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $688.1M | $725.2M | $743.6M |
| EPS | $0.01 | $0.03 | $0.07 |
| EBITDA | $395.2M | $419.1M | $435M |
| EBIT | $146.5M | $155.3M | $161.2M |
| Net income | $19.1M | $19.6M | $20M |
- Revenue$725.2M
- EPS$0.03
- EBITDA$419.1M
- EBIT$155.3M
- Net income$19.6M
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $738.8M | $694.6M | +6.4% | $0.28 | $0.05 | +430.7% |
- Q1 2026+6.4%+430.7%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Healthpeak Properties (DOC) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 3 analysts.
- Low
- $19.00
- Consensus
- $22.14
- Median
- $22.00
- High
- $24.00
- Current
- $22.19
- Upside
- -0.2%
Upside calculated vs most recent trading price of $22.19.
Analyst ratings
Consensus: Buy — based on 41 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 15, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 8, 2026 | UBS | maintain | Neutral | Neutral |
| Jul 7, 2026 | Barclays | downgrade | Overweight | Equal Weight |
| Jul 6, 2026 | Mizuho | maintain | Outperform | Outperform |
| Jun 24, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Jun 15, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Jun 11, 2026 | Morgan Stanley | downgrade | Overweight | Equal Weight |
| Jun 1, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| May 27, 2026 | Scotiabank | maintain | Sector Perform | Sector Perform |
| May 22, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
- Jul 15, 2026Wells FargoEqual Weight
- Jul 8, 2026UBSNeutral
- Jul 7, 2026BarclaysEqual Weight
- Jul 6, 2026MizuhoOutperform
- Jun 24, 2026JP MorganNeutral
- Jun 15, 2026BMO CapitalOutperform
- Jun 11, 2026Morgan StanleyEqual Weight
- Jun 1, 2026Wells FargoEqual Weight
- May 27, 2026ScotiabankSector Perform
- May 22, 2026Morgan StanleyOverweight
Frequently asked questions
Healthpeak Properties (DOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.64% TTM
- Dividend Profile5.50% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.